138 related articles for article (PubMed ID: 15210447)
21. Hyperhomocysteinaemia and cardiovascular risk in female ovariectomized rats: role of folic acid and hormone replacement therapy.
el-Swefy SE; Ali SI; Asker ME; Mohamed HE
J Pharm Pharmacol; 2002 Mar; 54(3):391-7. PubMed ID: 11902805
[TBL] [Abstract][Full Text] [Related]
22. Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.
Title LM; Ur E; Giddens K; McQueen MJ; Nassar BA
Vasc Med; 2006 May; 11(2):101-9. PubMed ID: 16886840
[TBL] [Abstract][Full Text] [Related]
23. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
[TBL] [Abstract][Full Text] [Related]
24. Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease.
Willems FF; Aengevaeren WR; Boers GH; Blom HJ; Verheugt FW
J Am Coll Cardiol; 2002 Aug; 40(4):766-72. PubMed ID: 12204509
[TBL] [Abstract][Full Text] [Related]
25. Homocysteine and heart disease in Indian Asians.
Brattström L
Lancet; 2000 Jun; 355(9222):2248; author reply 2250. PubMed ID: 10881911
[No Abstract] [Full Text] [Related]
26. Potential clinical and economic effects of homocyst(e)ine lowering.
Nallamothu BK; Fendrick AM; Rubenfire M; Saint S; Bandekar RR; Omenn GS
Arch Intern Med; 2000 Dec 11-25; 160(22):3406-12. PubMed ID: 11112233
[TBL] [Abstract][Full Text] [Related]
27. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
Yilmaz H; Sahin S; Sayar N; Tangurek B; Yilmaz M; Nurkalem Z; Onturk E; Cakmak N; Bolca O
Acta Cardiol; 2007 Dec; 62(6):579-85. PubMed ID: 18214123
[TBL] [Abstract][Full Text] [Related]
28. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid.
Fernández-Miranda C; Gómez P; Díaz-Rubio P; Estenoz J; Carillo JL; Andrés A; Morales JM
Clin Transplant; 2000 Apr; 14(2):110-4. PubMed ID: 10770414
[TBL] [Abstract][Full Text] [Related]
29. Homocysteine and heart disease in Indian Asians.
Ledochowski M; Bernhard W; Fuchs D
Lancet; 2000 Jun; 355(9222):2249; author reply 2250. PubMed ID: 10881913
[No Abstract] [Full Text] [Related]
30. Reduction of total homocysteine levels by oral folic acid fails to improve endothelial function in children with chronic renal failure.
Chan NN; Chan WB; Chan JC
Circulation; 2003 Jan; 107(1):e6-7; author reply e6-7. PubMed ID: 12515761
[No Abstract] [Full Text] [Related]
31. Hyperhomocysteinemia as a cause of vascular occlusion in end-stage-renal disease.
Tamura T; Bergman SM; Morgan SL
Int J Artif Organs; 1998 Feb; 21(2):72-4. PubMed ID: 9569127
[No Abstract] [Full Text] [Related]
32. Significant reduction of serum homocysteine level and oral symptoms after different vitamin-supplement treatments in patients with burning mouth syndrome.
Sun A; Lin HP; Wang YP; Chen HM; Cheng SJ; Chiang CP
J Oral Pathol Med; 2013 Jul; 42(6):474-9. PubMed ID: 23297780
[TBL] [Abstract][Full Text] [Related]
33. Folic Acid does not limit endothelial dysfunction induced by ischemia and reperfusion: a human study.
Dragoni S; Gori T; Di Stolfo G; Sicuro S; Forconi S; Parker JD
J Cardiovasc Pharmacol; 2005 Oct; 46(4):494-7. PubMed ID: 16160603
[TBL] [Abstract][Full Text] [Related]
34. Significant reduction of homocysteine level with multiple B vitamins in atrophic glossitis patients.
Sun A; Wang YP; Lin HP; Chen HM; Cheng SJ; Chiang CP
Oral Dis; 2013 Jul; 19(5):519-24. PubMed ID: 23130817
[TBL] [Abstract][Full Text] [Related]
35. Homocysteine and endothelial function in human studies.
Moat SJ; McDowell IF
Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine and coronary artery disease.
Futterman LG; Lemberg L
Am J Crit Care; 1997 Jan; 6(1):72-7. PubMed ID: 9116791
[No Abstract] [Full Text] [Related]
37. Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literature.
Taylor BV; Oudit GY; Evans M
Can Fam Physician; 2000 Nov; 46():2236-45. PubMed ID: 11143583
[TBL] [Abstract][Full Text] [Related]
38. Variations in the lipid profile of patients with chronic renal failure, treated with folic acid.
de Gómez Dumm NT; Giammona AM; Touceda LA
Int J Vitam Nutr Res; 2003 May; 73(3):215-20. PubMed ID: 12847999
[TBL] [Abstract][Full Text] [Related]
39. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients.
van Guldener C; Janssen MJ; de Meer K; Donker AJ; Stehouwer CD
J Intern Med; 1999 Feb; 245(2):175-83. PubMed ID: 10081520
[TBL] [Abstract][Full Text] [Related]
40. A tale of two homocysteines--and two hemodialysis units.
Hoffer LJ; Bank I; Hongsprabhas P; Shrier I; Saboohi F; Davidman M; Bercovitch DD; Barré PE
Metabolism; 2000 Feb; 49(2):215-9. PubMed ID: 10690947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
